Litcius/Paper detail

Pacritinib: First Approval

Yvette N. Lamb

2022Drugs69 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMyelofibrosisPolycythemia veraEssential thrombocythemiaRandomized controlled trialSafety profileInternal medicinePharmacologyAdverse effectBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsKruppel-like factors research
Pacritinib: First Approval | Litcius